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Backround/aim: Papillary thyroid carcinomas (PTC) frequently metastasize to regional lymph nodes. Our purpose was to investigate
the predictive role of tumor location for lymph node metastasis pattern in PTCs.
Materials and methods: Medical records of 110 PTC patients were reviewed retrospectively. Tumor location was determined as upper,
middle, and lower pole according to ultrasonography (USG) findings. The effects of age, sex, tumor size, and location on lymph node
metastasis were investigated.
Results: The series comprised 87% females (n = 96) and 13% males (n = 14). Forty-three patients had central neck metastasis (CNM)
and 14 had lateral neck metastasis (LNM). Upper pole tumors (UPT) metastasized to the central neck (CN) at a lower rate (17.6%)
than middle (40.0%) or lower (48.5%) poles overall (P = 0.104), while it was at a significantly lower rate (13.3%) in the PTC group (P <
0.05). UPTs (n = 17) metastasized to the lateral neck (LN) almost 2-fold more. It was observed that 3 of 4 UPTs spread directly to the
LN without CNM.
Conclusion: In our opinion, UPTs have propensity to demonstrate metastasis to LN rather than the CN in PTCs. Therefore, UPTs
should be evaluated meticulously in terms of LNM. New studies could suggest that CN dissection is not performed for low-risk PTCs
in UPTs.
Key words: Papillary thyroid cancer, lymph node metastasis, tumor location

1. Introduction
PTC constitutes approximately 80%–85% of all thyroid
cancers with reported 10-year survival of >90% (1). The
rate of metastases to the regional lymph nodes ranges
from 50% to 80% in some series (2–4). PTCs generally
metastasize to the CN more often than the LN (5).
Lymph node metastasis may be a risk factor for
recurrence and distant metastasis in PTC. CNM has poor
prognostic value but increases locoregional recurrence
(6). LNM also increases the risk of recurrence and distant
metastasis (7). In addition to the effects of metastases on
survival and recurrence, which are still open to discussion,

the effects of many prognostic factors such as age, sex,
primary tumor location, size of the tumor, extracapsular
spread, and histopathology have become issues in current
studies (1,6,7). In recent decades, clinical trials about
the effects of primary tumor location on lymph node
metastasis have provided conflicting results (1,6,7). PTC
mostly presents a sequential lymph node metastasis
pattern although a discontinuous lymph node metastasis
pattern is also possible. Lee et al. (7) reported that primary
tumors located in the upper pole of the thyroid gland are
closely linked to skipped metastases in the lateral cervical
neck.
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The aim of this study was to investigate the predictive
role of tumor location on central and lateral cervical
lymph node metastasis pattern in PTCs.
2. Materials and methods
The study was conducted at Dışkapı Yıldırım Beyazıt
Training and Research Hospital ENT Department after
the approval of the Ethics Committe. A retrospective
analysis was made of the medical records of 467 patients
who underwent thyroid surgery between January 2008
and June 2012. The last preoperative USG reports, fine
needle aspiration biopsy (FNAB) results, operation
notes, and postoperative histopathological results were
reviewed in detail. Patients were excluded if revision or
complementary thyroid surgery was performed, if there
were benign causes, or if other histological types of thyroid
carcinoma were determined. Multifocal or multicentric
tumors were also excluded. The patients in this study
were only those who underwent total thyroidectomy
(TT) plus either only central neck dissection (CND)
or CND with lateral neck dissection (LND). CND was
performed bilaterally to all patients whose FNAB results
were malignant. LND was performed if lateral cervical
lymph node metastasis was evident radiologically or
confirmed by ultrasound-guided FNAB and routinely
included neck levels 2, 3, and 4. Eventually, 110 PTC
patients were included in the study.
2.1. Evaluation of localization
The localization of the primary tumor was determined
according to the last preoperative USG report which had
been produced by the same team. It was checked from the
reports if the nodules were described as in the lower pole,
middle pole, upper pole, and isthmus. The descriptions
in the horizontal plane such as back, front, lateral and
medial settling patterns of the nodule were not taken
into consideration. Tumors localized in the isthmus were
evaluated as middle pole. The localization of the nodules
on the USG reports was confirmed by the histopathology
report.
2.2. Statistical analysis
Data were transferred from Excel files to IBM ISS 20
program and the analyses were completed. Before
analysis, the conformity of continuous variables to normal
distribution was assessed. If >50, the Kolmogorov–
Smirnov test was applied and if <50, the Shapiro–Wilk
test. As the age value conformed to the normality
hypothesis in both groups, the independent sample t-test
was applied in comparisons at 95% confidence interval.
The Pearson Chi-square test was applied to categorical
variables such as age, sex, tumor localization, side, and
micropapillary and papillary presence, which were
analyzed in respect of the metastasis effect to central and
lateral compartments.
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3. Results
The study included a total of 110 patients who underwent
TT + CND and/or TT + CND + LND. According to
the final pathology reports, PTC was determined in 65
patients (59%) and micropapillary carcinomas (mPTC)
in 45 (41%). The patients comprised 96 (87.3%) females
and 14 (12.7%) males with a mean age of 43.8 years (range,
19–85 years).
The effects of the variables of sex, tumor location, side,
and metastasis to the CN and LN were investigated for
both papillary and micropapillary carcinomas (Table 1).
The surgery types were also determined.
Primary tumors located in the upper pole, metastasized
to the central lymph nodes (level 6) at a lower rate (17.6%)
than those located in the middle (40.0%) or lower (48.5%)
poles (P = 0.104) (Table 2), and at a statistically significantly
lower rate (13.3%) in the PTC group (P < 0.05) (Table 3).
There was no significant relationship between the
tumor side and central metastasis pattern in both PTC and
mPTC patients.
3.1. Metastasis to lateral neck
Fourteen primary tumors metastasized to the LN (level
2-3-4). UPTs (n = 17) metastasized to the LN at almost
twice the rate (23.5%) of middle (11.7%) or lower pole
tumors (9.1%) (P = 0.326) (Table 2). Of 4 UPTs, 3 skipped
to the LN without CNM (Table 4). In the mPTC patients,
there was 1 LNM with CNM, located in the lower pole.
Statistical analysis could not be performed due to the low
numbers.
4. Discussion
In PTCs, the first lymphatic station in the neck is the
CN (level 6) and a high incidence of (up to 80%) occult
metastases have been identified in the central compartment
(2-4) . Metastasis to regional nodes is common in patients
with PTC and has been reported to be associated with
increased recurrence and compromised survival (8,9).
5-year survival rate is still reported with >99 % in PTCs
excellently. Involvement of regional lymph nodes decrease
this rate to 97 %, and in most cases is associated to higher
regional recurrence rates (3,10).
Consensus has been reached on the decision for lymph
node dissection if the central or lateral neck has evident
lymph node metastasis (11). However, the discussions
still continue for occult lymph node metastasis in
clinical or radiological N0 necks. In many studies, it has
been indicated that lymph node dissection has reduced
recurrence and has been a positive effect on survival (1214).
Since the importance of lymph node metastases is
now better understood, prognostic risk factors affecting
the nodal metastasis pattern need to be taken into
consideration in the decision for surgery. Metastases to
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Table 1. Demographic data of patients according to the PTC and mPTC.
PTC

Female

Sex

Location

Side

Surgery

Central metastasis
Lateral metastasis

mPTC

n

%

n

%

55

84.6

41

91.1

Male

10

15.4

4

8.9

Lower pole

17

26.2

16

35.6

Middle pole

33

50.7

27

60.0

Upper pole

15

23.1

2

4.4

Right lobe

31

47.7

21

46.7

Left lobe

29

44.6

24

53.3

Isthmus

5

7.7

0

0.0

TT + CND

52

81.5

44

97.8

TT + CND + LND

8

10.8

1

2.2

TT+CND+BLND

5

7.7

0

0.0

Absent

35

53.8

32

71.1

Present

30

46.2

13

28.9

Absent

52

80.0

44

97.8

Present

Total

13

20.0

1

2.2

65

100

45

100

CND, central neck dissection; LND, lateral neck dissection; BLND, bilateral neck dissection; TT,
total thyroidectomy.
Table 2. The relationship between location and metastasis for all patients.

Location

Lower
(n=33)

Middle
(n=60)

Upper
(n=17)

Total
(n=110)

16

24

3

43

Central metastasis
(P = 0.104)

n
%

48.5

40.0

17.6

39.1

Lateral metastasis
(P = 0.326)

n

3

7

4

14

%

9.1

11.7

23.5

12.7

Table 3. The relationship between location and metastasis in the PTC group.
Lower
(n=17)

Location
Central metastasis
(P = 0.014)
Lateral metastasis
(P = 0.558)

Middle
(n=33)

Upper
(n=15)

Total

n

10

18

2

30

%

58.8

54.5

13.3

46.2

n

2

7

4

13

%

11.8

21.2

26.7

20.0

the lateral neck have been found to have higher recurrence
rates than metastases to the central compartment (15).
In a study by Wang et al. (1), it was concluded that
tumors located in the middle and lower pole, tumors >0.5

cm in diameter, age <45 years and capsule invasion are
high risks for metastases to the central region.
Many authors researched the effect of intrathyroidal
tumor location on the pattern of lymph node metastasis
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Table 4. The relationship between tumor location and lateral
neck metastasis.
Localization

Central + Lateral

Lateral

Upper pole
(n=17)

1

3

Middle pole
(n=60)

5

2

Lower pole
(n=33)

3

and concluded that tumors located in the upper pole
tend to metastasize to the LN more frequently in PTC. It
was emphasized that the LN must be examined carefully
if the tumor is identified in the upper pole during the
preoperative evaluation (6,16,17).
PTC mostly presents a sequential lymph node
metastasis pattern, although a discontinuous lymph node
metastasis pattern is also possible (6,7). Lee et al. (7)
determined skip metastases to the LN in 9 patients where
the primary tumor was located in the upper pole according
to the ultrasonography findings. Ito et al. (18) determined
that in PTC, tumor cells located in the upper pole tend to
spread to the lateral lymph node throughout the superior
thyroid artery. Zhang et al. (19) investigated the relationship
between primary tumor location and nodal metastasis risk
and concluded that upper pole location is a low risk for the
central region but high risk for lateral region metastases.
American Head and Neck Society Consensus mentioned
PTC arising in the upper pole of the thyroid has a higher
propensity to demonstrate skip metastases to levels III and
II of the lateral compartment (20).
In the current series, CNM rates according to tumor
location of upper, middle, and lower pole were 17.6%,
40.0%, and 48.5%, respectively, overall. Although not
statistically significant, UPTs tended to CNM at a rate
2-fold lower and at a significantly lower rate (13.3%) in the
PTC group than the mPTC group (P < 0.05). UPTs (n =
17) metastasized to the LN at a rate almost twice (23.5%)
as that of middle (11.7%) or lower pole tumors (9.1%).
It was also observed that 3 of 4 UPTs skipped to the LN
without CNM.
Whether the primary tumor was in the right or left
lobe in both the papillary and micropapillary groups had
no effect on CNM. According to the current study data,
because of the low number of metastases to the LN, the
results were not as strong as in similar studies. However,
these results support the findings of similar previous
studies in the literature (1,6,7) since only 4 patients of
17 had upper pole-located primary tumor and 3 of those
skipped metastasis to the LN.
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The major drawback that diminishes the reliability
of these studies is that there is no standardization for
the determination of primary tumor location, and that
management of the neck differs locally in PTC (1,6,7).
In the preoperative assessment, USG is accepted as the
gold standard as it is inexpensive, noninvasive, and can
be applied simultaneously with FNAB. However, it should
be taken into consideration that results may change
depending on the practitioner and specifying lymph
nodes in the CN decreases the specificity and sensitivity
(21). While the localization of solitary tumors is easier,
determining the localization of multifocal or multicentric
tumors presents a significant challenge. In this study,
solitary PTCs according to pathology reports were
included even if the patient was diagnosed as multinodular.
Multifocal or multicentric tumors were excluded. Further
clinical trials are required to investigate the predictors of
the nodal metastasis pattern and these would be of benefit
in planning surgery. If specific results can be obtained by
subdividing the central region (paratracheal, pretracheal,
prelaryngeal etc.), surgeries could be planned which would
cause less morbidity.
In localization studies, including the current study, the
relationship of primary tumor location and the papillary
carcinoma histological subtypes has not been examined;
thus, the effects of subtypes of PTC on the lymph nodes
spread pattern can be considered to differ. In future
studies evaluating the effect of location on the lymph node
metastasis pattern, the effects of folliculary carcinoma,
and medullary and anaplastic carcinoma should also be
examined.
In conclusion, we think that the lymph node metastasis
pattern of primary tumors located in the upper pole of the
thyroid gland differs from those with middle and lower
pole localization. In our opinion, upper pole-located
tumors have propensity to demonstrate metastasis to
LN. We consider that UPTs should be evaluated more
carefully preoperatively and routine CND should not be
applied to these patients if there are no other prognostic
risk factors. Predictive prognostic factors should be
prospectively evaluated in wider patient series with more
detailed identification of tumor localization, taking into
account the histological subtypes with the specific and
standardized methods.
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